1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Frank L. Sapienza, MS, is affiliated with The Drug and Chemical Advisory Group LLC in Fairfax, Virginia. Sapienza has published research focusing on the safety and efficacy of esmethadone in treating major depressive disorder (MDD), including long-term studies and phase 3 randomized controlled trials assessing patients with inadequate response to standard antidepressants. Collaborators frequently include Andrea Mattarei, Andrew J. Cutler, Charles E. Inturrisi, Charles W. Gorodetzky, and Clotilde Guidetti.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
